PMID-sentid	Pub_year	Sent_text	compound_name	comp_offset	prot_official_name	organism	prot_offset
18056335-0	2007	L-type amino acid transporters LAT1 and LAT4 in cancer: uptake of 3-O-methyl-6-18F-fluoro-L-dopa in human adenocarcinoma and squamous cell carcinoma in vitro and in vivo.	3-O-methyl-6-fluoro-dopa	66-96	solute carrier family 7 member 5	Homo sapiens	31-35
20641250-12	2004	FDA can be O-methylated by catechol-O-methyltransferase (COMT) to 3-O-methyl-6-[(18)F]fluoro-L-dopa (3-OMFD), which is uniformly distributed throughout the brain.	3-O-methyl-6-fluoro-dopa	66-99	catechol-O-methyltransferase	Homo sapiens	27-55
20641250-12	2004	FDA can be O-methylated by catechol-O-methyltransferase (COMT) to 3-O-methyl-6-[(18)F]fluoro-L-dopa (3-OMFD), which is uniformly distributed throughout the brain.	3-O-methyl-6-fluoro-dopa	66-99	catechol-O-methyltransferase	Homo sapiens	57-61
20641250-12	2004	FDA can be O-methylated by catechol-O-methyltransferase (COMT) to 3-O-methyl-6-[(18)F]fluoro-L-dopa (3-OMFD), which is uniformly distributed throughout the brain.	3-O-methyl-6-fluoro-dopa	101-107	catechol-O-methyltransferase	Homo sapiens	27-55
20641250-12	2004	FDA can be O-methylated by catechol-O-methyltransferase (COMT) to 3-O-methyl-6-[(18)F]fluoro-L-dopa (3-OMFD), which is uniformly distributed throughout the brain.	3-O-methyl-6-fluoro-dopa	101-107	catechol-O-methyltransferase	Homo sapiens	57-61
18056335-0	2007	L-type amino acid transporters LAT1 and LAT4 in cancer: uptake of 3-O-methyl-6-18F-fluoro-L-dopa in human adenocarcinoma and squamous cell carcinoma in vitro and in vivo.	3-O-methyl-6-fluoro-dopa	66-96	solute carrier family 43 member 2	Homo sapiens	40-44
1939384-2	1991	In human studies with carbidopa pretreatment, L-3,4-dihydroxy-6-[18F]fluoro-3-O-methylphenylalanine (3-OMFD) was the only FDOPA metabolite detected in plasma.	3-O-methyl-6-fluoro-dopa	101-107	immunoglobulin kappa variable 2-14 (pseudogene)	Homo sapiens	46-49